Concepedia

Michael Recht

MR

80

Publications

6.8K

Citations

35

H-Index

1991

Active since

Affiliations

Oregon Health & Science University(Current)

American Thrombosis and Hemostasis Network

Novo Nordisk (United States)

Emory University

Indiana Hemophilia and Thrombosis Center

Michael Recht is an author at Oregon Health & Science University specializing in medicine, hematology, and thrombosis.

ORCID

Top concepts

Publications per year

1991–2025

80

Publications

80

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

Marilyn J. Manco‐Johnson, Thomas C. Abshire, Amy D. Shapiro et al. · New England Journal of Medicine · 2007 · 1.9K citations · Full text

Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

Amit Nathwani, Ulreke M. Reiss, Edward G. D. Tuddenham et al. · New England Journal of Medicine · 2014 · 1.2K citations · Full text

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Steven W. Pipe, Frank W.G. Leebeek, Michael Recht et al. · New England Journal of Medicine · 2023 · 307 citations · Full text

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

Lindsey A. George, Paul E. Monahan, M. Elaine Eyster et al. · New England Journal of Medicine · 2021 · 234 citations · Full text

A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma

Michael Recht, Ernest C. Borden, E. Knight · The Journal of Immunology · 1991 · 178 citations

Rows per page

1–5 of 80